Oracle Grants Options for 571K Shares to Chairman Larry Ellison
ORACLE CORP
Subscribe to track ORCL
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Oracle Grants Options for 571K Shares to Chairman Larry Ellison
Company: ORACLE CORP (ORCL) Form: 4 | Filed: 2025-10-27 Significance: Medium
Insider: ELLISON LAWRENCE JOSEPH Title: Executive Chairman, Chief Technology Officer | Relationship: Director, Officer, 10% Owner
Transaction: • Type: Grant (Stock Option) • Shares: 571,286 • Price: $0.00 • Value: $0 • Owned After: 571,286 options
Key Insight: Founder and Chairman Larry Ellison received a significant stock option grant, signaling continued long-term alignment with shareholder interests.
Market Context: The grant represents potential dilution of ~0.02% of outstanding shares, a minor impact for the $807B company, but reinforces the key executive's stake in future performance.
Comprehensive Analysis
SEC Filing Analysis: ORACLE CORP (ORCL)
Executive Summary
- Trading Significance: Medium
- Key Takeaway: Oracle's founder, Chairman, and CTO, Lawrence Ellison, received a stock option grant for 571,286 shares, reinforcing his long-term incentive alignment with the company.
- Market Impact: Neutral. This is a standard form of executive compensation for a key leader, and the potential dilution impact is minimal for a company of Oracle's size.
Company Information
| Field | Value |
|---|---|
| Company | ORACLE CORP |
| Ticker Symbol | ORCL |
| CIK | 0001341439 |
| Industry | SERVICES-PREPACKAGED SOFTWARE [7372] |
Insider Information
| Field | Value |
|---|---|
| Name | ELLISON LAWRENCE JOSEPH |
| CIK | 0000901999 |
| Title/Position | Executive Chairman, Chief Technology Officer |
| Relationship | Director, Officer, 10% Owner |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-10-23 |
| Transaction Code | A (Grant) |
| Security Type | Stock Option |
| Shares Involved | 571,286 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 571,286 (of this specific derivative) |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 |
| % of Market Cap | 0.00% |
| Shares Transacted | 571,286 |
| % of Shares Outstanding | 0.0201% |
| Post-Transaction Ownership | 571,286 options |
| Materiality Assessment | Low (based on quantitative metrics) |
Impact Evaluation
- Market Cap Context: For a mega-cap company with an $807.72 billion market capitalization, this grant has a negligible immediate financial impact. The significance lies in the signal it sends about executive incentives.
- Ownership Concentration: As a 10%+ owner, Larry Ellison's interests are already heavily aligned with shareholders. This grant further solidifies that alignment, though it represents a very small fraction of his total holdings.
- Dilution Impact: The potential dilution from these options, if exercised, is approximately 0.02% of total shares outstanding. This is a very low level of dilution and is unlikely to be a concern for investors.
- Transaction Significance: While the transaction's quantitative impact is low, its qualitative significance is Medium. A substantial equity grant to a founder who also serves as Chairman and CTO is a key indicator of the board's strategy for retaining and incentivizing top leadership.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: Equity grants to top executives are a routine part of compensation and are generally priced into market expectations. This action confirms long-term incentives are in place but does not represent a new cash investment or a change in strategy.
Volume & Sentiment
- Expected Volume Impact: Negligible. Compensation-related grants do not typically drive trading volume.
- Sentiment Indicator: Neutral to slightly Bullish. The grant ensures a critical leader is incentivized for long-term performance, which is a positive for long-term investors.
Investment Insights
Positive Market Indicators
- Reinforces long-term incentive alignment for a founder and key executive.
- The four-year annual vesting schedule encourages a sustained focus on company performance.
Risk Factors
- While this specific grant's dilution is minimal, investors should monitor the company's total equity compensation overhang as part of their overall analysis.
Key Takeaways
- Founder and Chairman Larry Ellison was granted 571,286 stock options.
- The grant has a 4-year vesting schedule, aligning incentives with long-term shareholder value creation.
- The potential dilution impact on existing shareholders is minimal at approximately 0.02%.
Additional Context
Transaction Notes
- The options carry an exercise price of $280.07 and expire in ten years, on October 23, 2035.
- Per the filing's footnote, 25% of the shares subject to the option will vest annually on each anniversary of the grant date.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
